Cegedim Belgium October marks the completion of your first full year as general manager of Cegedim’s Belgian affiliate. To what extent do you feel that the skills you’ve acquired in your career at Therabel and B Braun – both pharmaceutical and medical devices companies, apply to Cegedim? What were some of main…
Industrial Development Agency - Ireland Mr. O’Leary, when an article in The Guardian last year profiled you and your work, it was titled “Resurrecting the Celtic Tiger.” More recently, Time Magazine put Taoiseach Enda Kenny on its cover, and foretold of a “Celtic Revival.” Is this a time for optimism in the Irish economy? There…
Celgene China Celgene is a relative newcomer to China. What’s the story behind how the company entered the market, and how did you yourself come to manage the local operations? I officially joined Celgene on January 1st, 2011. Before that, I worked for Abraxis BioScience, a US-based biopharmaceutical company, which entered China…
Australia Would you begin by outlining the role & importance of George Clinical within the George Institute, highlighting recent milestones & achievements? George Clinical is an important division of the Institute, contributing to its research goals in several ways: We provide operations teams to deliver clinical trials i.e. the (usually) randomized,…
Australia Would you begin by giving an introduction to our international readers of the institute, highlighting recent milestones & achievements and the current focus areas of its research activities? Broadly speaking, The George Institute for Global Health is an academic research organization that focuses on high impact clinical research. We do…
The George Institute For those that are not familiar with your name, would you start by introducing yourself? After obtaining my PhD in cardiovascular physiology I moved to Boston to work at MIT on neurotransmitters in the brain and the effects on blood pressure. From Boston I moved to Hammersmith hospital in London…
Celgene Australia In our interviews we have been hearing two opinions on the success of PBS reforms: that it works as it should in providing space for innovative medicine listings, and that the number of listings has decreased to a point where Australia is in danger of losing its attractiveness as an…
Celgene Australia “Australia is not just a postbox for selling drugs; Celgene is committed to establishing a major presence in the region,” you said when Focus Reports met you first in 2008. Since then, what have been the highlights in the Celgene development in this part of the world? When Celgene decided…
Boehringer Ingelheim Singapore What is the presence of Boehringer Ingelheim (BI) in Southeast Asia? In 2009, Boehringer Ingelheim decided to establish a regional operating unit for its human pharmaceutical division (prescription and OTC products) in Southeast Asia that would be managed from Singapore. This business unit was designated to oversee of all the…
Boehringer Ingelheim Austria Austria has always been a strategic market for the group: it has played a key role in Boehringer Ingelheim’s success story, as this is where the company established its first foreign subsidiary in 1948. Can you give our readers a snapshot of the strategic importance Austria has today for the…
Singapore Management University (SMU) Since the last time we had the pleasure of meeting you, 4 years ago, what have been the main developments and changes in the Singaporean pharmaceutical industry? One of the most important changes was that Singapore and India signed a MoU; within this treaty Indian generic drugs will benefit from…
See our Cookie Privacy Policy Here
